(skip this header)

New Canaan News

Thursday, November 27, 2014

newcanaannewsonline.com Businesses

« Back to Article

Giusti recognized for advocacy, dedication

Published 9:17 am, Thursday, August 14, 2014
  • Kathy Giusti, of New Canaan, founder and executive chairman of the Multiple Myeloma Research Foundation board of directors, was named to the 2014 PharmaVOICE 100 list for her patient advocacy and dedication to advancing a cure. Photo: Contributed Photo / New Canaan News Contributed

    Kathy Giusti, of New Canaan, founder and executive chairman of the Multiple Myeloma Research Foundation board of directors, was named to the 2014 PharmaVOICE 100 list for her patient advocacy and dedication to advancing a cure.

    Photo: Contributed Photo

 

Larger | Smaller
Email This
Font
Page 1 of 1

Kathy Giusti, founder and executive chairman of the Multiple Myeloma Research Foundation board of directors, was named to the 2014 PharmaVOICE 100 list for her patient advocacy and dedication to advancing a cure.

PharmaVOICE describes the annual list as "inspirational individuals recognized for their positive contributions to the life-sciences industry," according to the organization.

Giusti, of New Canaan, was previously named to the list in 2009 for breaking down industry barriers.

As described in the PharmaVOICE 100 issue, "Kathy Giusti has been inspiring patients and the research community since she first took that powerful and visionary step. Her and MMRF's success has been built on three cornerstones: setting the vision and plan; hiring the talented people; and building a strong collaborative community."

Longtime member of the MMRF board of directors, Meryl Zausner, executive vice president and chief financial officer of Novartis Corp., also was recognized as a 2014 PharmaVOICE 100 honoree for her work in empowering women in the industry. Zausner and Giusti share an additional accolade of both being previous Healthcare Businesswomen's Association Women of the Year honorees.

"This is a well-deserved honor for both Kathy and Meryl," said Walter M. Capone, president and CEO of the MMRF. "Their leadership, commitment and advocacy has enabled the tremendous successes of the MMRF and will ensure our continued focus on speed, innovation and results for patients."

PharmaVOICE states that honorees are nominated by readers and are selected based on how they have inspired peers, affected positive change and given back to their communities.